References
- Andersen M. E., Gargas M. L., Jones R. A., Jenkins L. J., Jr. The use of inhalation techniques to assess the kinetic constants of 1, 1-dichloroethylene metabolism. Toxicol. Appl. Pharmacol. 1979; 47: 395–409
- Andersen M. E., Cargas M. L., Ramsey J. C. Inhalation pharmacokinetics: Evaluating systemic extraction, total in vivo metabolism, and the time course of enzyme induction for inhaled styrene in rats based on arterial blood: inhaled air concentration ratios. Toxicol. Appl. Pharmacol. 1984; 73: 176–187
- Andersen M. E., Clewell H. J., III, Cargas M. L., Smith F. A., Reitz R. H. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 1987a; 87: 185–205
- Andersen M. E., Cargas M. L., Clewell H. J., III, Severyn K. M. Quantitative evaluation of the metabolic interactions between trichloroethylene and 1, 1-dichloroethylene in vivo using gas uptake methods. Toxicol. Appl. Pharmacol. 1987b; 89: 149–157
- Corley R. A., Mendrala A. L., Smith F. A., Staats D. A., Cargas M. L., Conolly R. B., Andersen M. E., Reitz R. H. Development of a physiologically based pharmacokinetic model for chloroform. Toxicol. Appl. Pharmacol. 1990; 103: 512–527
- Evans M. V., Crank W. D., Yang H. M., Simmons J. E. Applications of sensitivity analysis to a physiologically-based pharmacokinetic model for carbon tetrachloride in rats. Toxicol. Appl. Pharmacol. 1994; 128: 36–44
- Filser J. C., Bolt H. M. Pharmacokinetics of halogenated ethylenes in rats. Arch. Toxicol. 1979; 42: 123–136
- Filser J. C., Bolt H. M. Inhalation pharmacokinetics based on gas uptake studies. I. Improvement of kinetic models. Arch. Toxicol. 1981; 47: 279–292
- Gargas M. L., Andersen M. E., Clewell H. J., III. A physiologically based simulation approach for determining metabolic constants from gas uptake data. Toxicol. Appl. Pharmacol. 1986; 86: 341–352
- Gargas M. L., Burgess R. J., Voisard D. E., Cason C. E., Andersen M. E. Partition coefficients of low-molecular-weight volatile chemicals in various liquids and tissues. Toxicol. Appl. Pharmacol. 1989; 98: 87–99
- Gargas M. L., Clewell H. J., III, Andersen M. E. Gas uptake inhalation techniques and the rates of metabolism of chloromethanes, chloroethanes, and chloroethylenes in the rat. Inhal. Toxicol. 1990; 2: 295–319
- Hetrick D. M., Jarabek A. M., Travis C. C. Sensitivity analysis for physiologically-based pharmacokinetic models. J. Pharmacokinet. Biopharm. 1991; 19: 1–20
- Kohn M. C., Melnick R. L. Species differences in the production and clearance of 1, 3-buta-diene metabolites: A mechanistic model indicates predominantly physiological, not biochemical, control. Carcinogenesis 1993; 14: 619–628
- Paustenbach D. J., Clewell H. J., III, Cargas M. L., Andersen M. E. A physiologically based pharmacokinetic model for inhaled carbon tetrachloride. Toxicol. Appi. Pharmacol. 1988; 96: 191–211
- Ramsey J C, Andersen M. E. A physiologically based description of the inhalation pharmacokinetics of styrene monomer in rats and humans. Toxicol. Appl. Pharmacol. 1984; 72: 159–175
- Reitz R. H., McDougal I. N., Himmelstein M. W., Nolan R. J., Schumann A. M. Physiologically based pharmacokinetic modeling with methylchloroform: Implications for interspecies, high dose/low dose, and dose route extrapolations. Toxicol. Appl. Pharmacol. 1988; 95: 185–199
- Yetter R. A., Dryer F. L., Rabitz H. Some interpretive aspects of elementary sensitivity gradients in combustion kinetics modeling. Combust. Flame 1985; 59: 107–133